Skip to main content
logo
Perspective Therapeutics, Inc. (CATX)
NYSEAMERICAN: CATX · Real-Time Price · USD
2.750
+0.130 (4.96%)
At close: Sep 30, 2026, 4:00 PM EDT
2.750
0.00 (0.00%)
Pre-market: Oct 1, 2026, 4:03 AM EDT

Perspective Therapeutics Ratios and Metrics

Millions USD. Fiscal year is Jan - Dec.

Total Valuation

Fiscal Year
CurrentFY 2025FY 2024FY 2023FY 2022FY 2022
Period Ending
Sep '26 Dec '25 Dec '24 Dec '23 Dec '22 Jun '22
Market Capitalization
3142042161133544
Market Cap Growth
26.17%-5.18%91.16%221.19%-19.99%-61.12%
Enterprise Value
8134-4898-19-14
Last Close Price
2.752.753.194.022.473.09

Price Ratios

Fiscal Year
CurrentFY 2025FY 2024FY 2023FY 2022FY 2022
Period Ending
Sep '26 Dec '25 Dec '24 Dec '23 Dec '22 Jun '22
Forward PE
-21.5121.5121.5121.5121.51
PS Ratio
767.52231.26148.2878.656.49-
PB Ratio
0.970.990.741.500.640.72
P/TBV Ratio
1.111.220.90147.820.640.72

EV Ratios

Fiscal Year
CurrentFY 2025FY 2024FY 2023FY 2022FY 2022
Period Ending
Sep '26 Dec '25 Dec '24 Dec '23 Dec '22 Jun '22
EV/Sales Ratio
198.0538.02-68.42--

Financial Efficiency

Fiscal Year
CurrentFY 2025FY 2024FY 2023FY 2022FY 2022
Period Ending
Sep '26 Dec '25 Dec '24 Dec '23 Dec '22 Jun '22
Debt / Equity Ratio
0.010.020.010.03-0.01
Net Debt / Equity Ratio
-0.72-0.68-0.77-0.09-0.80-0.90
Net Debt / EBITDA Ratio
1.921.283.460.175.169.02
Net Debt / FCF Ratio
1.921.493.070.184.106.94
Asset Turnover
0.000.000.010.02--
Quick Ratio
6.495.0812.530.6714.4725.38
Current Ratio
6.615.1712.681.0817.0726.18
Return on Equity (ROE)
-39.57%-41.65%-42.82%-57.70%--9.79%
Return on Assets (ROA)
-22.27%-23.34%-19.02%-32.81%--5.95%
Return on Capital Employed (ROCE)
-35.20%-47.70%-20.70%-49.80%-16.00%-10.30%

Yields

Fiscal Year
CurrentFY 2025FY 2024FY 2023FY 2022FY 2022
Period Ending
Sep '26 Dec '25 Dec '24 Dec '23 Dec '22 Jun '22
Earnings Yield
-37.09%-50.44%-36.77%-41.23%-30.64%-16.57%
FCF Yield
-38.60%-46.59%-33.72%-33.68%-30.42%-18.17%
Buyback Yield / Dilution
-29.45%-14.57%-140.72%-88.38%-0.06%-36.73%
SEC Filings: 10-K · 10-Q